Showing results (151-160 of 435) with videos related to

Sort By:
Pageof 44
American Heart Journal|December 6, 2011
Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationaleClaudia Zierold, Marjorie A Carlson, Udo C Obodo, et al.
The Journal of Clinical Investigation|August 15, 2017
Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytesCarlos A Ramos, Brandon Ballard, Huimin Zhang, et al.
The Journal of Clinical Investigation|June 9, 2016
Clinical responses with T lymphocytes targeting malignancy-associated κ light chainsCarlos A Ramos, Barbara Savoldo, Vicky Torrano, et al.
Molecular Therapy. Methods & Clinical Development|May 28, 2015
Optimizing the production of suspension cells using the G-Rex "M" seriesPradip Bajgain, Roopa Mucharla, John Wilson, et al.
Blood|May 16, 2009
Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopesPatrick J Hanley, Conrad Russell Young Cruz, Barbara Savoldo, et al.
Nature Medicine|September 26, 2006
Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individualsAnn M Leen, G Doug Myers, Uluhan Sili, et al.
Blood|October 11, 2011
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastomaChrystal U Louis, Barbara Savoldo, Gianpietro Dotti, et al.
Cytotherapy|May 1, 2010
Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experienceConrad Russell Cruz, Patrick J Hanley, Hao Liu, et al.
The Lancet. Oncology|June 19, 2010
Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysisMary Eapen, Vanderson Rocha, Guillermo Sanz, et al.
Blood|April 24, 2013
Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantationAnn M Leen, Catherine M Bollard, Adam M Mendizabal, et al.
Pageof 44